Proteomics approach and techniques in identification of reliable biomarkers for diseases

Raed Abdullah Alharbi, Raed Abdullah Alharbi

Abstract

Biomarkers, also called biological markers, are indicators to identify a biological case or situation as well as detecting any presence of biological activities and processes. Proteins are considered as a type of biomarkers based on their characteristics. Therefore, proteomics approach is one of the most promising approaches in this field. The purpose of this review is to summarize the use of proteomics approach and techniques to identify proteins as biomarkers for different diseases. This review was obtained by searching in a computerized database. So, different researches and studies that used proteomics approach to identify different biomarkers for different diseases were reviewed. Also, techniques of proteomics that are used to identify proteins as biomarkers were collected. Techniques and methods of proteomics approach are used for the identification of proteins' activities and presence as biomarkers for different types of diseases from different types of samples. There are three essential steps of this approach including: extraction and separation of proteins, identification of proteins, and verification of proteins. Finally, clinical trials for new discovered biomarker or undefined biomarker would be on.

Keywords: Bioinformatics; Biological markers; Diseases biomarkers; Protein informatics; Proteomics.

Conflict of interest statement

The authors declared that there is no conflict of interest.

© 2020 The Author(s).

Figures

Fig. 1
Fig. 1
The process of methods of proteomics approach to identify reliable biomarkers.

References

    1. Aulbach A., Amuzie C. Second ed. Academic Press; 2017. Chapter 17 - Biomarkers in Nonclinical Drug Development. A Comprehensive Guide to Toxicology in Nonclinical Drug Development; pp. 447–471. ISBN 9780128036204.
    1. Bharucha Tehmina, Gangadharan Bevin, Kumar Abhinav, de Lamballerie Xavier, Newton Paul N., Winterberg Markus, Dubot-Pérès Audrey, Zitzmann Nicole. Mass spectrometry-based proteomic techniques to identify cerebrospinal fluid biomarkers for diagnosing suspected central nervous system infections. A systematic review. J. Infect. 2019;79(5):407–418.
    1. Biomarkers Definitions Working Group Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 2001;69(3):89–95. Review PubMed PMID: 11240971.
    1. Bonnet J., Garcia C., Leger T., Couquet M.P., Vignoles P., Vatunga G., Ndung'u J., Boudot C., Bisser S., Courtioux B. Proteome characterization in various biological fluids of Trypanosoma brucei gambiense-infected subjects. J. Proteomics. 2019;30(196):150–161. Epub 2018 Nov 7 PubMed PMID: 30414516.
    1. Brody Tom. Second ed. Academic Press; 2016. Biomarkers Clinical Trials; pp. 377–419.
    1. Byrum Stephanie, Siegel Eric R., Bhattacharyya Sudeepa, Suva Larry J. Academic Press; 2010. Proteomics of Bone Cancer. Bone Cancer; pp. 171–180.
    1. Cao X., Limbach P.A. 2017. Mass Spectrometry: Nucleic Acids and Nucleotides Studied Using MS Encyclopedia of Spectroscopy and Spectrometry; pp. 764–771. (Elsevier).
    1. Cordeiro Ana, Pereira Rosiane, Chapeaurouge Alex, Coimbra Clarice, Perales Jonas, Oliveira Guilherme, Candiani Talitah, Coimbra Roney. Comparative proteomics of cerebrospinal fluid reveals a predictive model for differential diagnosis of pneumococcal, meningococcal, and enteroviral meningitis, and novel putative therapeutic targets. BMC Genomics. 2015;16(Suppl 5):S11.
    1. Corthell J. Protein identification using MS/MS data. J. Proteomics. 2011;74(10):1842–1845.
    1. Corthell John T. Immunohistochemistry Basic Molecular Protocols in Neuroscience: Tips, Tricks, and Pitfalls. Academic Press. 2014:91–103.
    1. Davis Myrtle A., Eldridge Sandy, Louden Calvert. Third ed. Academic Press; 2013. Chapter 10 - Biomarkers: Discovery, Qualification and Application. Haschek and Rousseaux's Handbook of Toxicologic Pathology; pp. 317–352.
    1. Delwiche L, Slaughter S. The Little SAS® Book: A Primer, Fifth ed. Chapter 8 and chapter9. 2012 Oct. SAS Institute. ISBN# 978-1-61290-343-9.
    1. DePrimo S.E. Biomarkers. Comprehensive Medicinal Chemistry II. Elsevier. 2007:69–85.
    1. Doustjalali S. Two dimensional gel electrophoresis: an overview of proteomic technique in cancer research. J. Proteom. Bioinformat. 2014;07
    1. Drew C, Shieh W. Chapter 10 - Immunohistochemistry. Current Laboratory Techniques in Rabies Diagnosis, Research and Prevention. Pages 109-115. Academic Press. 2015 Feb. ISBN 9780128019191. doi: 10.1016/b978-0-12-801919-1.00010-5.
    1. Clinical Gershwin L. Sixth ed. Academic Press; 2008. Veterinary Immunology. Clinical Biochemistry of Domestic Animals; pp. 157–172.
    1. He Jianwen. Fourth ed. Elsevier; 2013. Chapter 5.1 – Practical Guide to ELISA Development. The Immunoassay Handbook; pp. 381–393.
    1. Huss Ralf. Academic Press; 2015. Chapter 19 – Biomarkers Translational Regenerative Medicine; pp. 235–241.
    1. IBM. SPSS Statistics, Put the power of advanced statistical analysis in your hands. 2019. Retrieved from .
    1. Immer U., Lacorn M. Handbook of Food Allergen Detection and Control. Elsevier; 2015. Enzyme-linked immunosorbent assays (ELISAs) for detecting allergens in food; pp. 199–217.
    1. Karagiannis G.S., Pavlou M.P., Saraon P., Musrap N., Xie A., Batruch I., Prassas I., Dimitromanolakis A., Petraki C., Diamandis E.P. In-depth proteomic delineation of the colorectal cancer exoproteome: Mechanistic insight and identification of potential biomarkers. J. Proteomics. 2014;30(103):121–136. Epub 2014 Mar 27 PubMed PMID: 24681409.
    1. Kisluk Joanna, Ciborowski Michal, Niemira Magdalena, Kretowski Adam, Niklinski Jacek. Proteomics biomarkers for non-small cell lung cancer. J. Pharm. Biomed. Anal. 2014;101:40–49.
    1. Lafler K. Basic SAS PROCedures for Generating Quick Results. Paper 256-29.SAS. 2001. SAS Alliance Partner, and SAS Certified Professional are registered trademarks of SAS Institute Inc. in the USA and other countries.
    1. Liu Wentao, Yang Qiumeng, Liu Bingya, Zhu Zhenggang. Serum proteomics for gastric cancer. Clin. Chim. Acta. 2014;431:179–184.
    1. Maloy S., Brenner's Hughe K. 2nd ed. Academic Press, Elsevier; London: 2013. Encyclopedia of Genetics.
    1. Marín-García José. Post-Genomic Cardiology. Elsevier; 2007. Molecular and Biochemical Methodology in the Post-Genomic Era; pp. 11–25.
    1. Mayeux Richard. Biomarkers: potential uses and limitations. Neurotherapeutics. 2004;1(2):182–188.
    1. Matrix Science. Moscat Server. 2019. Retrieved from .
    1. Mellon F.A. Encyclopedia of Food Sciences and Nutrition. Elsevier; 2003. Mass Spectrometry | Principles and Instrumentation; pp. 3739–3749.
    1. Njunge J.M., Oyaro I.N., Kibinge N.K., Rono M.K., Kariuki S.M., Newton C.R., Berkley J.A., Gitau E.N. Cerebrospinal fluid markers to distinguish bacterial meningitis from cerebral malaria in children. Wellcome Open Res. 2017;26(2):47. eCollection 2017. PubMed PMID: 29181450; PubMed Central PMCID: PMC5686508.
    1. Oyejide L., Mendes O.R., Mikaelian I. Second ed. Academic Press; 2017. Molecular Pathology: A Comprehensive Guide to Toxicology in Nonclinical Drug Development; pp. 407–445.
    1. Patel S., Ling J., Kim S.J., Schey K.L., Rose K., Kuchtey R.W. Proteomic analysis of macular fluid associated with advanced glaucomatous excavation. JAMA Ophthalmol. 2016;134(1):108–110.
    1. Personalized Medicine Coalition (PMC). Advocates for Precision Medicine: Types of Biomarkers. 2019. Retrieved from .
    1. Ray Animikh, Cholkar Kishore, Wang Zhiying, Mitra Ashim K. Woodhead Publishing; 2013. Characterization of ocular transporters. Ocular Transporters and Receptors; pp. 85–114.
    1. Rodriguez H. CPTAC, the Complementary Sibling of TCGA: An Interview with Dr. Henry Rodriguez about NCI’s Proteomics Program. National Cancer Institute at the National Institutes of Health. 2015
    1. Roy Jyoti, Jain Neha, Singh Garima, Das Basudeb, Mallick Bibekanand. AGO-Driven Non-Coding RNAs. Elsevier; 2019. Small RNA proteome as disease biomarker: An incognito treasure of clinical utility; pp. 101–136.
    1. Roy P., Shukla Y. Applications of proteomic techniques in cancer research. Cancer Therapy. 2008;6(2):841–856. 16p.
    1. Sabino F, Hermes O, Auf dem Keller U. Body Fluid Degradomics and Characterization of Basic N-Terminome. Methods Enzymol. 2017 ;585:177-199. doi: 10.1016/bs.mie.2016.09.018. Epub 2016 Oct 19. PubMed PMID: 28109429.
    1. Sandalakis Vassilios, Goniotakis Ioannis, Vranakis Iosif, Chochlakis Dimosthenis, Psaroulaki Anna. Use of MALDI-TOF mass spectrometry in the battle against bacterial infectious diseases: recent achievements and future perspectives. Expert Rev. Proteom. 2017;14(3):253–267.
    1. Shah Tapan R., Misra Ambikanandan. Elsevier; 2011. Proteomics Challenges in Delivery of Therapeutic Genomics and Proteomics; pp. 387–427.
    1. Strimbu K., Tavel J.A. What are biomarkers? Curr. Opin. HIV AIDS. 2010;5(6):463–466. Review. PubMed PMID: 20978388; PubMed Central PMCID: PMC3078627.
    1. Swiss Institute of Bioinformatics (SIB). NNF Center for Protein Research, and European Molecular Biology Laboratory, STRING program. 2019. Retrieved from .
    1. Wang K, Ottens A, Haskins W, Liu M, Kobeissy F, Denslow N, Chen S, Hayes R. Proteomics Studies of Traumatic Brain Injury, International Review of Neurobiology. Pages 215-240. Academic Press. 2004 Oct. 0074-7742. ISBN 9780123668639. doi: 10.1016/s0074-7742(04)61009-9.
    1. Wang Qihui, Yu Qiaoling, Lin Qingyu, Duan Yixiang. Emerging salivary biomarkers by mass spectrometry. Clin. Chim. Acta. 2015;438:214–221.
    1. Yang J., Zhou M., Zhao R., Peng S., Luo Z., Li X., Cao L., Tang K., Ma J., Xiong W., Fan S., Schmitt D.C., Tan M., Li X., Li G. Identification of candidate biomarkers for the early detection of nasopharyngeal carcinoma by quantitative proteomic analysis. J. Proteomics. 2014;23(109):162–175. Epub 2014 Jul 3 PubMed PMID: 24998431.
    1. Zhao P, Sun M. Chapter 11 - The Maternal-to-Zygotic Transition in Higher Plants: Available Approaches, Critical Limitations, and Technical Requirements. Current Topics in Developmental Biology. Pages 373-398. Academic Press. 2015 Jul 0070-2153. ISBN 9780124095236. doi: 10.1016/bs.ctdb.2015.06.006.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere